184 related articles for article (PubMed ID: 22768121)
1. Enhanced membrane pore formation through high-affinity targeted antimicrobial peptides.
Arnusch CJ; Pieters RJ; Breukink E
PLoS One; 2012; 7(6):e39768. PubMed ID: 22768121
[TBL] [Abstract][Full Text] [Related]
2. Position-dependent hydrophobicity of the antimicrobial magainin peptide affects the mode of peptide-lipid interactions and selective toxicity.
Tachi T; Epand RF; Epand RM; Matsuzaki K
Biochemistry; 2002 Aug; 41(34):10723-31. PubMed ID: 12186559
[TBL] [Abstract][Full Text] [Related]
3. De novo generation of short antimicrobial peptides with enhanced stability and cell specificity.
Kim H; Jang JH; Kim SC; Cho JH
J Antimicrob Chemother; 2014 Jan; 69(1):121-32. PubMed ID: 23946320
[TBL] [Abstract][Full Text] [Related]
4. Enhanced membrane pore formation by multimeric/oligomeric antimicrobial peptides.
Arnusch CJ; Branderhorst H; de Kruijff B; Liskamp RM; Breukink E; Pieters RJ
Biochemistry; 2007 Nov; 46(46):13437-42. PubMed ID: 17944489
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.
Maher S; McClean S
Biochem Pharmacol; 2006 Apr; 71(9):1289-98. PubMed ID: 16530733
[TBL] [Abstract][Full Text] [Related]
6. Hybrids made from antimicrobial peptides with different mechanisms of action show enhanced membrane permeabilization.
Wade HM; Darling LEO; Elmore DE
Biochim Biophys Acta Biomembr; 2019 Oct; 1861(10):182980. PubMed ID: 31067436
[TBL] [Abstract][Full Text] [Related]
7. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic.
Breukink E; Wiedemann I; van Kraaij C; Kuipers OP; Sahl HG; de Kruijff B
Science; 1999 Dec; 286(5448):2361-4. PubMed ID: 10600751
[TBL] [Abstract][Full Text] [Related]
8. A proline-hinge alters the characteristics of the amphipathic α-helical AMPs.
Lee JK; Gopal R; Park SC; Ko HS; Kim Y; Hahm KS; Park Y
PLoS One; 2013; 8(7):e67597. PubMed ID: 23935838
[TBL] [Abstract][Full Text] [Related]
9. Selective toxicity of antimicrobial peptide S-thanatin on bacteria.
Wu G; Wu H; Fan X; Zhao R; Li X; Wang S; Ma Y; Shen Z; Xi T
Peptides; 2010 Sep; 31(9):1669-73. PubMed ID: 20600431
[TBL] [Abstract][Full Text] [Related]
10. Enhanced membrane permeabilization and antibacterial activity of a disulfide-dimerized magainin analogue.
Dempsey CE; Ueno S; Avison MB
Biochemistry; 2003 Jan; 42(2):402-9. PubMed ID: 12525167
[TBL] [Abstract][Full Text] [Related]
11. Magainins as paradigm for the mode of action of pore forming polypeptides.
Matsuzaki K
Biochim Biophys Acta; 1998 Nov; 1376(3):391-400. PubMed ID: 9804997
[TBL] [Abstract][Full Text] [Related]
12. Peptoid-Substituted Hybrid Antimicrobial Peptide Derived from Papiliocin and Magainin 2 with Enhanced Bacterial Selectivity and Anti-inflammatory Activity.
Shin A; Lee E; Jeon D; Park YG; Bang JK; Park YS; Shin SY; Kim Y
Biochemistry; 2015 Jun; 54(25):3921-31. PubMed ID: 26053120
[TBL] [Abstract][Full Text] [Related]
13. Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.
Han HM; Gopal R; Park Y
Amino Acids; 2016 Feb; 48(2):505-22. PubMed ID: 26450121
[TBL] [Abstract][Full Text] [Related]
14. Comparative mode of action of novel hybrid peptide CS-1a and its rearranged amphipathic analogue CS-2a.
Joshi S; Bisht GS; Rawat DS; Maiti S; Pasha S
FEBS J; 2012 Oct; 279(20):3776-90. PubMed ID: 22883393
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence and Absorbance Spectroscopy Methods to Study Membrane Perturbations by Antimicrobial Host Defense Peptides.
Arias M; Vogel HJ
Methods Mol Biol; 2017; 1548():141-157. PubMed ID: 28013502
[TBL] [Abstract][Full Text] [Related]
16. Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections.
Pandit G; Biswas K; Ghosh S; Debnath S; Bidkar AP; Satpati P; Bhunia A; Chatterjee S
Biochim Biophys Acta Biomembr; 2020 Apr; 1862(4):183177. PubMed ID: 31954105
[TBL] [Abstract][Full Text] [Related]
17. Effects and mechanisms of the secondary structure on the antimicrobial activity and specificity of antimicrobial peptides.
Mai XT; Huang J; Tan J; Huang Y; Chen Y
J Pept Sci; 2015 Jul; 21(7):561-8. PubMed ID: 25826179
[TBL] [Abstract][Full Text] [Related]
18. Lipid topology and electrostatic interactions underpin lytic activity of linear cationic antimicrobial peptides in membranes.
Paterson DJ; Tassieri M; Reboud J; Wilson R; Cooper JM
Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8324-E8332. PubMed ID: 28931578
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial Peptide CMA3 Derived from the CA-MA Hybrid Peptide: Antibacterial and Anti-inflammatory Activities with Low Cytotoxicity and Mechanism of Action in Escherichia coli.
Lee JK; Seo CH; Luchian T; Park Y
Antimicrob Agents Chemother; 2016 Jan; 60(1):495-506. PubMed ID: 26552969
[TBL] [Abstract][Full Text] [Related]
20. Lipid composition-dependent membrane fragmentation and pore-forming mechanisms of membrane disruption by pexiganan (MSI-78).
Lee DK; Brender JR; Sciacca MF; Krishnamoorthy J; Yu C; Ramamoorthy A
Biochemistry; 2013 May; 52(19):3254-63. PubMed ID: 23590672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
